TrialSite News is an independent and censorship-free media outlet dedicated to providing transparent coverage of clinical research in the health and biomedical field. Launched in late 2018, TrialSiteNews aims to increase interest and awareness in clinical research while fostering trust and engagement among researchers and the public. They serve as a disruptive force in the world of biomedical research, highlighting the trial sites and their staff, including hospitals, health systems, community clinics, and research centers.

TrialSiteNews publishes breakthroughs, challenges, best practices, and mishaps in clinical trials, offering a comprehensive understanding of the nuts and bolts of the process. With a mission to drive awareness, transparency, and engagement, TrialSiteNews values transparency, objectivity, and the scientific method in pursuit of the truth. Led by experienced management including CEO Daniel O’Connor, TrialSiteNews is committed to providing reliable and informative content to a wide audience, from pharmaceutical professionals and researchers to regulators and healthcare professionals.

For editorial inquiries or to share important information, readers can contact TrialSiteNews via email. Explore their website to learn more about their publications, services, and team